Australia: A more transparent Therapeutic Goods Administration?

Last Updated: 25 July 2011
Article by Jessica Kinny and Wendy Blacker

On 20 July 2011 the Australian Government released a report that could be the catalyst for greater transparency in the operation and regulation of the therapeutic goods industry.

On 16 November 2010 Parliamentary Secretary for Health and Ageing, Catherine King, announced that a review was to be commissioned in response to community concern about the lack of information made available by the Therapeutic Goods Administration (TGA).  The focus of the review was to improve the TGA's transparency to ensure that the public is better informed about the TGA's regulatory processes and the benefits and risk of therapeutic goods. 

The review was undertaken by the Therapeutic Goods Administration Transparency Review Panel (the Panel), chaired by Professor Dennis Pearce.  There were 13 members on the Panel; each member representing the main stakeholder groups of consumers, health practitioners, the rural health sector and the therapeutic goods industry.  The five members representing the therapeutic goods industry represented the following sectors: prescription medicines; generic prescription medicines; over-the-counter medicines; complementary medicines; and medical devices.

The Panel commenced operation on 10 December 2010 with a view to providing a report by 29 April 2011.  That date was extended to 30 June 2011 when the size of the task, and the extent of the public interest in the review, was realised. 

Executive summary: key recommendations of the Panel

The consultations carried out by the Panel during the review highlighted the need for the TGA to devise and implement strategies to improve communications between the TGA and its key stakeholders.  

A copy of the Review Report, which contains detailed information regarding each recommendation, is available here.  An executive summary of the unanimous recommendations of the Panel are contained in the Final Report titled 'Review to improve the transparency of the Therapeutic Goods Administration' (the Report) and are as follows.

Recommendations for raising stakeholder involvement in the TGA

1.       The TGA establish an Australian Therapeutic Goods Advisory Council made up of representatives of major stakeholder groups that holds an oversight role in the implementation, ongoing monitoring and evaluation of the recommendations of the Report.

2.       The TGA develop, implement and publish consultation principles to ensure regulatory transparency and accountability.

3.       The TGA develop and implement a comprehensive communication strategy geared to inform and educate the community and stakeholders.  The establishment of a TGA communications team was recommended to achieve this objective. 

4.       The TGA work transparently with other key providers of information to enhance the information available to stakeholders and members of the community.

5.       The TGA develop a plan to ensure information on the key public access portal, the TGA website, is current, accurate and relevant and meets the needs of its audiences.

6.       The TGA provide user-friendly information on the risk based framework under which it operates; particularly information on the difference between registered and listed therapeutic goods and their processes of evaluation.

7.       The TGA implement mechanisms to inform the public that listed medicines are not evaluated for effectiveness by the TGA prior to market.

8.       The TGA provide clear information on the role of its statutory advisory committees, and adopt a consistent and transparent approach to the publication of information from those committees.

9.       The TGA improve access to and quality of information on the regulation of advertising of therapeutic goods.  This is to include information on the complaint process and the outcomes of complaints.

10.   The TGA, in conjunction with key stakeholders, develop and publish agreed key performance indicators on the TGA's organisational effectiveness and operational efficiency.

Recommendations for improving market authorisation processes

11.   The TGA develop and publish a policy on the disclosure of commercially confidential information, noting significant issues for each therapeutic product type.  The policy is to take into account the practices followed by comparable international regulators.

12.   The TGA explore ways of explaining its various regulatory processes to the public and adopt publication principles on the outcomes of application assessments using as an exemplar the Australian Public Assessment Reports.

13.   The TGA assess and report on the feasibility of developing an online system for the submission and tracking of all applications for assessment.  This system is to include a means of allowing the sponsor to track the progress of an application.

14.   The TGA work with stakeholders to improve labelling and packaging requirements.  The purpose of implementing this recommendation will be to educate consumers and health practitioners so they may make informed decisions about the quality use of therapeutic goods.

Recommendations to improve monitoring and compliance

15.   The TGA conduct, and report on, a feasibility study into the development of an early post marketing risk communication scheme for therapeutic goods.  International models are to be considered when devising the scheme.

16.   The TGA actively promote the distribution of therapeutic goods safety information and consider ways of improving the timely communication of alerts and recalls to health practitioners and consumers.

17.   The TGA explore ways of maintaining the currency of Consumer Medicine Information and Approved Product Information.

18.   The TGA progressively develop and implement a system to publish the outcomes of investigations and compliance actions taken.

19.   The TGA more effectively facilitate the recognition and reporting of adverse events by health practitioners and consumers, and promote the adverse event reporting system.

20.   The TGA make its Adverse Events Database available to, and searchable by, the public in a manner that supports the quality use of therapeutic goods.

21.   The TGA work with State and Territory Governments, stakeholders, and other relevant agencies, to improve the visible management of adverse event reporting in support of consumer safety and consistent with the finding of the Horvath Review into Immunisation.

The Government will now consider the Review Panel Report and provide a formal response to these recommendations.

contact us
For more information, please contact:

Sydney



Wendy Blacker

t (02) 9931 4922

e wblacker@nsw.gadens.com.au

 

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Jessica Kinny
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert
Email Address
Company Name
Password
Confirm Password
Mondaq Topics -- Select your Interests
Accounting and Audit
Anti-trust/Competition Law
Consumer Protection
Corporate/Commercial Law
Criminal Law
Employment and HR
Energy and Natural Resources
Environment
Family and Matrimonial
Finance and Banking
Food, Drugs, Healthcare, Life Sciences
Government, Public Sector
Immigration
Insolvency/Bankruptcy, Re-structuring
Insurance
Intellectual Property
International Law
Litigation, Mediation & Arbitration
Media, Telecoms, IT, Entertainment
Privacy
Real Estate and Construction
Strategy
Tax
Transport
Wealth Management
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.